These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2076896)

  • 1. Production and characterization of anti-RAS p21 monoclonal antibodies.
    Hamer PJ; Trimpe KL; Pullano T; Ng S; LaVecchio JA; Petit DA; DeLellis R; Wolfe H; Carney WP
    Hybridoma; 1990 Dec; 9(6):573-87. PubMed ID: 2076896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas.
    Garlick DS; Sukumar S; Barbacid M; Petit D; Hamer PJ; Leav I; Lavecchio JA; Trimpe KL; Carney WP
    Hybridoma; 1991 Feb; 10(1):95-102. PubMed ID: 2032737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of monoclonal antibodies to Ha-ras and N-ras p21.
    Ng S; Conlon J; Lavecchio J; Hamer PJ; Pullano T; Carney WP
    Hybridoma; 1991 Aug; 10(4):467-80. PubMed ID: 1937497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
    La Vecchio JA; Hamer PJ; Ng SC; Trimpe KL; Carney WP
    Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K; Naz RK
    Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and properties of monoclonal antibodies against intact H-ras p21 proteins.
    Sorrentino V; Nebreda AR; Alonso T; Santos E
    Oncogene; 1989 Feb; 4(2):215-22. PubMed ID: 2467247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative immunofluorescence, anti-ras p21 antibody specificity, and cellular oncoprotein levels.
    Jones PL; O'Hare CM; Bass RA; Rao JY; Hemstreet GP; Hurst RE
    Biochem Biophys Res Commun; 1990 Mar; 167(2):464-70. PubMed ID: 2138889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21.
    Kuzumaki N; Oda A; Yamagiwa S; Taniguchi N; Kobayashi H; Oikawa T
    J Natl Cancer Inst; 1986 Dec; 77(6):1273-9. PubMed ID: 3540418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
    Hamer PJ; La Vecchio J; Ng S; DeLellis R; Wolfe H; Carney WP
    Oncogene; 1991 Sep; 6(9):1609-15. PubMed ID: 1923528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61.
    Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM
    Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generation and characterization of monoclonal antibody against HSD11B1].
    Wang W; Yang JJ; Liu L; Chen ZC; Gao Y; Gao JE; An LG; Sun QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):38-40. PubMed ID: 18177616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites.
    Werge TM; Bradbury A; Di Luzio A; Cattaneo A
    Oncogene; 1992 May; 7(5):1033-5. PubMed ID: 1570149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological effects of the microinjection of antibody to ras p21 in early cleavage Xenopus embryos.
    Miron MJ; Lanoix J; Paiement J
    Mol Reprod Dev; 1990 Apr; 25(4):317-27. PubMed ID: 2183830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ras-like proteins in embryonic and adult cells of Xenopus laevis.
    Hanocq-Quertier J; Hanocq F
    Mol Reprod Dev; 1991 Apr; 28(4):325-36. PubMed ID: 2064775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins.
    Kung HF; Smith MR; Bekesi E; Manne V; Stacey DW
    Exp Cell Res; 1986 Feb; 162(2):363-71. PubMed ID: 3510879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel monoclonal antibody raised against human hepatocellular carcinoma.
    Xie Y; Xie H
    Hybridoma; 1998 Oct; 17(5):437-44. PubMed ID: 9873989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of ras oncogene product p21 in human endometrial carcinoma.
    Yaginuma Y; Fujita M; Saitoh S; Hayakawa K; Kuzumaki N; Ishikawa M
    Acta Histochem; 1993 Sep; 95(1):23-9. PubMed ID: 8279232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular expression of the monoclonal anti-ras antibody Y13-259 blocks the transforming activity of ras oncogenes.
    Montano X; Jimenez A
    Cell Growth Differ; 1995 May; 6(5):597-605. PubMed ID: 7647040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.